Showing results (111-120 of 195) with videos related to
Sort By:
Pageof 20
The Journal of Urology|February 1, 2015
Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve MenClaire de la Calle, Dattatraya Patil, John T Wei, et al.Analytical Chemistry|February 18, 2026
High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression AnalysisJongmin Woo, Zhenyu Sun, Yingwei Hu, et al.Cancers|May 13, 2026
A Biomarker Panel for the Detection of Pancreatic CancerYuefan Wang, Yuanyu Huang, Tung-Shing M Lih, et al.Biorxiv : the Preprint Server for Biology|July 14, 2025
High-Sensitive Spatial Proteomics for Pancreatic Cancer Progression AnalysisJongmin Woo, Zhenyu Sun, Yingwei Hu, et al.Urology|December 15, 2004
Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%Masood A Khan, Lori J Sokoll, Daniel W Chan, et al.Clinical Proteomics|January 25, 2019
Validation of a novel model for the early detection of hepatocellular carcinomaPhilip M Hemken, Lori J Sokoll, Xiaoqing Yang, et al.Journal of Proteome Research|December 17, 2008
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working groupMelissa K Tuck, Daniel W Chan, David Chia, et al.The Journal of Urology|January 15, 2013
The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculatorDonna P Ankerst, Cathee Till, Andreas Boeck, et al.Biometrical Journal. Biometrische Zeitschrift|November 19, 2011
Updating risk prediction tools: a case study in prostate cancerDonna P Ankerst, Tim Koniarski, Yuanyuan Liang, et al.Clinical Chemistry|October 15, 2005
Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometryJinong Li, Rosaria Orlandi, C Nicole White, et al.Pageof 20